friends of FSH Research


Over 10 Years of Creating Hope

The mission of Friends of FSH Research is to accelerate the discoveries that will lead to treatments or cures for FSHD. To achieve our goal, we actively manage a portfolio of research that supports a pipeline for drug discovery. Our board, staff, volunteers, and world-class scientists are fully committed to transparent, reproducible, and transformative science that will inspire hope for people with FSHD. Learn more >>

Auction Catalogs Now Available

The Live Auction Catalog is available for download here.

The Silent Auction Catalog is also available for download here.

And Don't Forget - Research Update

On the afternoon of the auction you are invited to attend
a research update meeting in the Rainier Room.
See details.

facebook twitter pinterest instagram

Over $3.6 million

funded to date


Attracted to research

Check Out Your Impact >>

"Hopefully one day FSHD will be stopped in its tracks. I know that there is still a long road ahead, with many milestones to pass but the journey isn’t quite so scary knowing that I am not alone and that there are those willing to keep pushing ahead, guiding the way until we find the key to unlock that final door."

- T. Pilato

Our vision: One day the diagnosis of FSH Muscular Dystrophy will be followed by "...there is a treatment."

Upcoming Events

Wellstone Research Update
— January 27th, 2018

A discussion on recent research advances at the Hyatt prior to the Annual Auction.

A Royal Affair
— January 27th, 2018


Latest News

Pre-clinical Safety and Off-Target Studies to Support Translation of AAV-Mediated RNAi Therapy for FSHD

— January 17, 2018

A publication from Scott Harper's lab reporting on the use of an AAV vector to test the safety of two miRNAs in…

Progress Report: 3rd Gen Oligonucleotide Targeting DUX4 in Mouse Model

— January 1, 2018

Yi-Wen Chen DMV PhD provides an update on investigating 3rd generation oligonucleotides.

Progress Report: Utilization of cell-free DNA as a biomarker

— December 31, 2017

Initial progress report provided by Premi Haynes PhD.

MRI change metrics of facioscapulohumeral muscular dystrophy: STIR and T1

— December 16, 2017

Follow-on publication for previously funded grant.

Progress Report: Defining the role of post-translational modification on FSHD protein DUX4

— December 15, 2017

Jocelyn Eidahl, Post-Doctoral Scientist at Nationwide Children’s Hospital provides a progress update.


Ask the Expert

Therapy Q&A

by Amanda Rickard

Interview of Dr. Joel Chamberlain regarding her lab's work on therapy development.
to